Synplogen collaborates with Ginkgo Bioworks

Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan

Synplogen Co., a synthetic biology startup spun out of Kobe University’s Graduate School of Science, Technology and Innovation that provides custom DNA synthesis and Gene Therapy Biofoundry services, and Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a non-binding Memorandum of Understanding (“MOU”). Together, Synplogen […]

Aptar appoints Sarah Glickman to its Board of Directors

Sarah Glickman, Board of Directors, Aptar

AptarGroup, Inc. , a global leader in drug and consumer product dosing, dispensing and protection technologies, yesterday announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. “We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah’s extensive […]

Aptar designates Julie Xing to its board of directors

AptarGroup, Inc. a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced recently that Julie Xing has joined its Board of Directors. With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in […]

AcroMeta gain a LOA for USD 6.1mln design and build works

AcroMeta Group Limited, an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biotechnology, pharmaceutical, research and academia sectors, has received a letter of award (“LOA”) for the design and build of laboratory and office space worth approximately S USD6.1 million from a global clinical research organisation that helps […]